Today, only 1% of eligible patient candidates for Bariatric and Metabolic Surgery are choosing to get surgery even though there are now good results, specialist teams and specialty hospitals available to them. The market is growing steadily and large, a 1% market penetration represents a about $500M annual US market for laparoscopic mechanical stapling technology, and is ripe for a major disruption.” GT Metabolic Solutions is that major disruption. We are dedicated to revolutionizing gastric bypass. From the procedure to the recovery, our skilled team of engineers and surgeons are dedicated to providing effective solutions never before seen by the medical community.
Over the last decade, the GT Technology and IP were incubated and have produced over 17 patents to date by GT’s world-renowned founding staff. The Co-Founders of GT Metabolic Solutions are visionary surgeon Michel Gagner (Cleveland Clinic, Mt. Sinai School of Medicine, Cornell University, University of Montreal) and entrepreneur business professional Thierry Thaure (Abbott, Intuitive, Accuray, EGS, Guidant). Dr. Gagner invented and pioneered the “Sleeve Gastrectomy”, the new gold standard procedure for the treatment of severe obesity and/or type-2 diabetes in use today in approximately 70% of the world’s 500,000 Bariatric procedures. He is known and respected by every single laparoscopic bariatric surgeon in the world. Thaure is a known serial company builder and has spent close to 35 years in Medical Technologies specializing in building surgical and cardiology companies. With the addition of Todd Krinke, GT’s innovative Vice President of Research & Development, the team is unstoppable in pioneering this new frontier in bariatric surgery.
Our technology enables surgeons to offer a less invasive surgical standard of care with incision-less intervention and enteric bypass connection without bleeding or leaks. All procedures are out-patient, have the potential to be performed under deep sedation, and will decrease intervention/hospital costs. Our technology also allows surgeons to decouple today’s procedure and change the paradigm of how surgeons manage both obese and metabolic (diabetic) patients. Further, this technology has potential to disrupt other fields in colorectal and gastrointestinal surgery in the near future.
